Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313366438> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W4313366438 endingPage "187.10" @default.
- W4313366438 startingPage "187.10" @default.
- W4313366438 abstract "Abstract The Ikaros family of transcription factors (TFs) are important regulators of lymphocyte function. However, their roles in human innate lymphoid cell (ILC) function remain unclear. Here, we found that Ikaros (IKZF1) is expressed by all ILC subsets, including NK cells, in blood, tonsil and gut, while Helios (IKZF2) is preferentially expressed by ILC3 in tonsil and gut. Aiolos (IKZF3) followed the expression pattern of T-bet and Eomes, being predominantly expressed by ILC1 and NK cells. Differentiation of IFN-γ-producing ILC1 and NK cells from ILC3 by IL-1β plus IL-12-stimulation was associated with upregulation of T-bet and Aiolos. Selective degradation of Aiolos and Ikaros by lenalidomide suppressed ILC1 and NK cell differentiation and expression of ILC1 and NK cell-related transcripts (LEF1, PRF1, GRZB, CD244, NCR3, IRF8). In line with reduced ILC1/NK cell differentiation we observed an increase in the expression of the ILC3-related TF Helios, as well as ILC3 transcripts (TNFSF13B, IL22, NRP1 and RORC) and in the frequency of IL-22 producing ILC3 in cultures with IL-1β and IL-23. These data suggest that suppression of Aiolos and Ikaros expression inhibits ILC1 and NK cell differentiation while ILC3 function is maintained. Hence, our results open up for new possibilities in targeting Ikaros family TFs for modulation of type 1/3 immunity in inflammation and cancer." @default.
- W4313366438 created "2023-01-06" @default.
- W4313366438 creator A5006950170 @default.
- W4313366438 creator A5009570364 @default.
- W4313366438 creator A5022878443 @default.
- W4313366438 creator A5032597940 @default.
- W4313366438 creator A5035144590 @default.
- W4313366438 creator A5036206227 @default.
- W4313366438 creator A5070381365 @default.
- W4313366438 creator A5076472763 @default.
- W4313366438 creator A5080628718 @default.
- W4313366438 creator A5088737122 @default.
- W4313366438 date "2019-05-01" @default.
- W4313366438 modified "2023-10-01" @default.
- W4313366438 title "Suppression of Aiolos and Ikaros expression by lenalidomide reduces human ILC3–ILC1/NK cell transdifferentiation" @default.
- W4313366438 doi "https://doi.org/10.4049/jimmunol.202.supp.187.10" @default.
- W4313366438 hasPublicationYear "2019" @default.
- W4313366438 type Work @default.
- W4313366438 citedByCount "0" @default.
- W4313366438 crossrefType "journal-article" @default.
- W4313366438 hasAuthorship W4313366438A5006950170 @default.
- W4313366438 hasAuthorship W4313366438A5009570364 @default.
- W4313366438 hasAuthorship W4313366438A5022878443 @default.
- W4313366438 hasAuthorship W4313366438A5032597940 @default.
- W4313366438 hasAuthorship W4313366438A5035144590 @default.
- W4313366438 hasAuthorship W4313366438A5036206227 @default.
- W4313366438 hasAuthorship W4313366438A5070381365 @default.
- W4313366438 hasAuthorship W4313366438A5076472763 @default.
- W4313366438 hasAuthorship W4313366438A5080628718 @default.
- W4313366438 hasAuthorship W4313366438A5088737122 @default.
- W4313366438 hasConcept C104317684 @default.
- W4313366438 hasConcept C203014093 @default.
- W4313366438 hasConcept C2779341262 @default.
- W4313366438 hasConcept C47742525 @default.
- W4313366438 hasConcept C502942594 @default.
- W4313366438 hasConcept C54355233 @default.
- W4313366438 hasConcept C86339819 @default.
- W4313366438 hasConcept C86803240 @default.
- W4313366438 hasConcept C8891405 @default.
- W4313366438 hasConcept C95444343 @default.
- W4313366438 hasConceptScore W4313366438C104317684 @default.
- W4313366438 hasConceptScore W4313366438C203014093 @default.
- W4313366438 hasConceptScore W4313366438C2779341262 @default.
- W4313366438 hasConceptScore W4313366438C47742525 @default.
- W4313366438 hasConceptScore W4313366438C502942594 @default.
- W4313366438 hasConceptScore W4313366438C54355233 @default.
- W4313366438 hasConceptScore W4313366438C86339819 @default.
- W4313366438 hasConceptScore W4313366438C86803240 @default.
- W4313366438 hasConceptScore W4313366438C8891405 @default.
- W4313366438 hasConceptScore W4313366438C95444343 @default.
- W4313366438 hasIssue "1_Supplement" @default.
- W4313366438 hasLocation W43133664381 @default.
- W4313366438 hasOpenAccess W4313366438 @default.
- W4313366438 hasPrimaryLocation W43133664381 @default.
- W4313366438 hasRelatedWork W2039597291 @default.
- W4313366438 hasRelatedWork W2078875613 @default.
- W4313366438 hasRelatedWork W2100120771 @default.
- W4313366438 hasRelatedWork W2294037042 @default.
- W4313366438 hasRelatedWork W2749632265 @default.
- W4313366438 hasRelatedWork W2754140340 @default.
- W4313366438 hasRelatedWork W2900558465 @default.
- W4313366438 hasRelatedWork W2900916646 @default.
- W4313366438 hasRelatedWork W3030208661 @default.
- W4313366438 hasRelatedWork W3031062651 @default.
- W4313366438 hasVolume "202" @default.
- W4313366438 isParatext "false" @default.
- W4313366438 isRetracted "false" @default.
- W4313366438 workType "article" @default.